Year |
Citation |
Score |
2024 |
Finnigan JP, Newman JH, Patskovsky Y, Patskovska L, Ishizuka AS, Lynn GM, Seder RA, Krogsgaard M, Bhardwaj N. Structural basis for self-discrimination by neoantigen-specific TCRs. Nature Communications. 15: 2140. PMID 38459027 DOI: 10.1038/s41467-024-46367-9 |
0.343 |
|
2023 |
Patskovsky Y, Natarajan A, Patskovska L, Nyovanie S, Joshi B, Morin B, Brittsan C, Huber O, Gordon S, Michelet X, Schmitzberger F, Stein RB, Findeis MA, Hurwitz A, Van Dijk M, ... ... Krogsgaard M, et al. Molecular mechanism of phosphopeptide neoantigen immunogenicity. Nature Communications. 14: 3763. PMID 37353482 DOI: 10.1038/s41467-023-39425-1 |
0.37 |
|
2023 |
Finnigan J, Newman J, Patskovsky Y, Patskovska L, Ishizuka A, Lynn G, Seder R, Krogsgaard M, Bhardwaj N. Structural Basis for Self-Discrimination by Neoantigen-Specific TCRs. Research Square. PMID 36778273 DOI: 10.21203/rs.3.rs-2531184/v1 |
0.373 |
|
2020 |
Deng J, Thennavan A, Shah S, Bagdatlioglu E, Klar N, Heguy A, Marier C, Meyn P, Zhang Y, Labbe K, Almonte C, Krogsgaard M, Perou CM, Wong KK, Adams S. Serial single-cell profiling analysis of metastatic TNBC during Nab-paclitaxel and pembrolizumab treatment. Breast Cancer Research and Treatment. PMID 32949350 DOI: 10.1007/S10549-020-05936-4 |
0.389 |
|
2020 |
Yoshida T, Ichikawa J, Giuroiu I, Laino AS, Hao Y, Krogsgaard M, Vassallo M, Woods DM, Stephen Hodi F, Weber J. C reactive protein impairs adaptive immunity in immune cells of patients with melanoma. Journal For Immunotherapy of Cancer. 8. PMID 32303612 DOI: 10.1136/Jitc-2019-000234 |
0.439 |
|
2019 |
Krogsgaard M, Moogk D, Li K, Yuan Z, Osman I, Weber JS, Zhu C. Abstract PR08: Mechanisms of primary resistance to PD-1 checkpoint blockade Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-Pr08 |
0.429 |
|
2019 |
Deng J, Shah S, Thennavan A, Krogsgaard M, Perou CM, Wong K, Adams S. Abstract 4044: The immune phenotype in serial biopsies from metastatic TNBC undergoing chemo-immunotherapy Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-4044 |
0.349 |
|
2019 |
Moogk D, Wang L, Li K, Yuan Z, Weber J, Osman I, Zhu C, Krogsgaard M. Abstract 3236: T-cell intrinsic mechanisms of resistance to PD-1 checkpoint blockade Immunology. DOI: 10.1158/1538-7445.Sabcs18-3236 |
0.372 |
|
2018 |
Natarajan A, Krogsgaard M. The myriad targets of a T cell. Nature Biotechnology. 36: 1152-1154. PMID 30520863 DOI: 10.1038/Nbt.4309 |
0.499 |
|
2018 |
Gowen MF, Giles KM, Simpson D, Tchack J, Zhou H, Moran U, Dawood Z, Pavlick AC, Hu S, Wilson MA, Zhong H, Krogsgaard M, Kirchhoff T, Osman I. Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors. Journal of Translational Medicine. 16: 82. PMID 29606147 DOI: 10.1186/S12967-018-1452-4 |
0.371 |
|
2018 |
Moogk D, Natarajan A, Krogsgaard M. T cell receptor signal transduction: affinity, force and conformational change Current Opinion in Chemical Engineering. 19: 43-50. DOI: 10.1016/J.Coche.2017.12.007 |
0.544 |
|
2017 |
Weiss SA, Han SW, Lui K, Tchack J, Shapiro R, Berman R, Zhong J, Krogsgaard M, Osman I, Darvishian F. Corrigendum to "Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma" (Hum Pathol 2016;57:116-25). Human Pathology. PMID 28449825 DOI: 10.1016/J.Humpath.2017.03.001 |
0.343 |
|
2016 |
Weiss SA, Han J, Darvishian F, Tchack J, Han SW, Malecek K, Krogsgaard M, Osman I, Zhong J. Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohorts. Journal of Translational Medicine. 14: 299. PMID 27760559 DOI: 10.1186/S12967-016-1026-2 |
0.732 |
|
2016 |
Weiss SA, Han SW, Lui K, Tchack J, Shapiro R, Berman R, Zhong J, Krogsgaard M, Osman I, Darvishian F. Immunologic heterogeneity of tumor infiltrating lymphocyte composition in primary melanoma. Human Pathology. PMID 27473267 DOI: 10.1016/J.Humpath.2016.07.008 |
0.397 |
|
2016 |
Moogk D, Zhong S, Yu Z, Liadi I, Rittase W, Fang V, Dougherty J, Perez-Garcia A, Osman I, Zhu C, Varadarajan N, Restifo NP, Frey AB, Krogsgaard M. Constitutive Lck Activity Drives Sensitivity Differences between CD8+ Memory T Cell Subsets. Journal of Immunology (Baltimore, Md. : 1950). PMID 27271569 DOI: 10.4049/Jimmunol.1600178 |
0.438 |
|
2016 |
Natarajan A, Nadarajah V, Felsovalyi K, Wang W, Jeyachandran VR, Wasson RA, Cardozo T, Bracken C, Krogsgaard M. Structural Model of the Extracellular Assembly of the TCR-CD3 Complex. Cell Reports. PMID 26997265 DOI: 10.1016/J.Celrep.2016.02.081 |
0.397 |
|
2016 |
Vogelsang M, Martinez CN, Rendleman J, Bapodra AB, Malecek K, Romanchuk A, Kazlow E, Shapiro RL, Berman RS, Krogsgaard M, Osman I, Kirchhoff T. The expression quantitative trait loci in immune pathways and their effect on cutaneous melanoma prognosis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26733611 DOI: 10.1158/1078-0432.Ccr-15-2066 |
0.726 |
|
2016 |
Weiss SA, Tchack J, Han J, Darvishian F, Shapiro RL, Krogsgaard M, Zhong J, Osman I. Impact of aging on immune response and survival in melanoma. Journal of Clinical Oncology. 34: e21079-e21079. DOI: 10.1200/Jco.2016.34.15_Suppl.E21079 |
0.371 |
|
2015 |
Rendleman J, Vogelsang M, Bapodra A, Adaniel C, Silva I, Moogk D, Martinez CN, Fleming N, Shields J, Shapiro R, Berman R, Pavlick A, Polsky D, Shao Y, Osman I, ... Krogsgaard M, et al. Genetic associations of the interleukin locus at 1q32.1 with clinical outcomes of cutaneous melanoma. Journal of Medical Genetics. 52: 231-9. PMID 25604082 DOI: 10.1136/Jmedgenet-2014-102832 |
0.31 |
|
2015 |
Moogk D, Li T, Lee C, Pires Da Silva IED, Ma MW, Friedman EB, Vega-Saenz de Miera E, Darvishian F, Scanlon P, Perez-Garcia A, Pavlick AC, Bhardwaj N, Christos PJ, Osman I, Krogsgaard M. Association of melanoma expression of matrix metalloproteinase-23 with blunted tumor immunity and poor responses to immunotherapy. Journal of Clinical Oncology. 33: e20057-e20057. DOI: 10.1200/Jco.2015.33.15_Suppl.E20057 |
0.45 |
|
2015 |
Weiss SA, Han SW, Vogelsang M, Krogsgaard M, Lui KP, Shapiro RL, Kirchhoff T, Darvishian F, Osman I. Tumor infiltrating lymphocyte (TIL) classifications and association with survival in primary melanomas. Journal of Clinical Oncology. 33: e20042-e20042. DOI: 10.1200/Jco.2015.33.15_Suppl.E20042 |
0.379 |
|
2014 |
Moogk D, da Silva IP, Ma MW, Friedman EB, de Miera EV, Darvishian F, Scanlon P, Perez-Garcia A, Pavlick AC, Bhardwaj N, Christos PJ, Osman I, Krogsgaard M. Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy. Journal of Translational Medicine. 12: 342. PMID 25491880 DOI: 10.1186/S12967-014-0342-7 |
0.449 |
|
2014 |
Malecek K, Grigoryan A, Zhong S, Gu WJ, Johnson LA, Rosenberg SA, Cardozo T, Krogsgaard M. Specific increase in potency via structure-based design of a TCR. Journal of Immunology (Baltimore, Md. : 1950). 193: 2587-99. PMID 25070852 DOI: 10.4049/Jimmunol.1302344 |
0.801 |
|
2014 |
Wang W, Li T, Felsovalyi K, Chen C, Cardozo T, Krogsgaard M. Quantitative analysis of T cell receptor complex interaction sites using genetically encoded photo-cross-linkers. Acs Chemical Biology. 9: 2165-72. PMID 25061810 DOI: 10.1021/Cb500351S |
0.408 |
|
2014 |
Crites TJ, Padhan K, Muller J, Krogsgaard M, Gudla PR, Lockett SJ, Varma R. TCR Microclusters pre-exist and contain molecules necessary for TCR signal transduction. Journal of Immunology (Baltimore, Md. : 1950). 193: 56-67. PMID 24860189 DOI: 10.4049/jimmunol.1400315 |
0.345 |
|
2014 |
Krogsgaard M. Imprinting of the mature T cell response by self. Trends in Immunology. 35: 141-3. PMID 24646828 DOI: 10.1016/J.It.2014.03.002 |
0.49 |
|
2014 |
Liu B, Zhong S, Malecek K, Johnson LA, Rosenberg SA, Zhu C, Krogsgaard M. 2D TCR-pMHC-CD8 kinetics determines T-cell responses in a self-antigen-specific TCR system. European Journal of Immunology. 44: 239-50. PMID 24114747 DOI: 10.1002/Eji.201343774 |
0.779 |
|
2014 |
Rendleman J, Adaniel C, Kern E, Fleming NH, Krogsgaard M, Polsky D, Berman RS, Shapiro RL, Pavlick AC, Shao Y, Osman I, Kirchhoff T. The genetic variants in interleukin locus at 1q32.1 as markers of melanoma survival. Journal of Clinical Oncology. 32: 9094-9094. DOI: 10.1200/Jco.2014.32.15_Suppl.9094 |
0.374 |
|
2014 |
Fleming NH, Lui KP, Shapiro RL, Berman RS, Pavlick AC, Zhong J, Krogsgaard M, Pires Da Silva IED, Osman I. Dissecting the effect of age on immune response in melanoma patients. Journal of Clinical Oncology. 32: 9058-9058. DOI: 10.1200/Jco.2014.32.15_Suppl.9058 |
0.342 |
|
2014 |
Malecek K, Grigoryan A, Zhong S, Gu WJ, Johnson LA, Rosenberg SA, Cardozo T, Krogsgaard M. Specific increase in T-cell potency via structure-based design of a T-cell receptor for adoptive immunotherapy. Journal of Clinical Oncology. 32: 3063-3063. DOI: 10.1200/Jco.2014.32.15_Suppl.3063 |
0.806 |
|
2014 |
Moogk D, Ma MW, Pires Da Silva IED, Friedman EB, Vega-Saenz de Miera E, Darvishian F, Perez-Garcia A, Scanlon P, Pavlick AC, Bhardwaj N, Christos PJ, Osman I, Krogsgaard M. Matrix metalloproteinase-23 as a new immunotherapeutic checkpoint target in melanoma. Journal of Clinical Oncology. 32: 3030-3030. DOI: 10.1200/Jco.2014.32.15_Suppl.3030 |
0.452 |
|
2014 |
Malecek K, Grigoryan A, Zhong S, Gu WJ, Johnson LA, Rosenberg SA, Cardozo T, Krogsgaard M. Specific increase in T cell potency via structure-based design of a T cell receptor for adoptive immunotherapy Journal For Immunotherapy of Cancer. 2. DOI: 10.1186/2051-1426-2-S3-P28 |
0.787 |
|
2014 |
Zhong S, Malecek K, Moogk D, Johnson LA, Yu Z, Grigoryan A, Vega-Saenz de Miera E, Darvishian F, Gu W, McGary K, Huang K, Boyer J, Corse E, Yongzhao S, Rosenberg SA, ... ... Krogsgaard M, et al. Engineering the immune response to "self" for effective cancer immunotherapy Journal For Immunotherapy of Cancer. 2: P22. DOI: 10.1186/2051-1426-2-S3-P22 |
0.775 |
|
2013 |
Havukainen H, Münch D, Baumann A, Zhong S, Halskau Ø, Krogsgaard M, Amdam GV. Vitellogenin recognizes cell damage through membrane binding and shields living cells from reactive oxygen species. The Journal of Biological Chemistry. 288: 28369-81. PMID 23897804 DOI: 10.1074/Jbc.M113.465021 |
0.322 |
|
2013 |
Wei F, Zhong S, Ma Z, Kong H, Medvec A, Ahmed R, Freeman GJ, Krogsgaard M, Riley JL. Strength of PD-1 signaling differentially affects T-cell effector functions. Proceedings of the National Academy of Sciences of the United States of America. 110: E2480-9. PMID 23610399 DOI: 10.1073/Pnas.1305394110 |
0.421 |
|
2013 |
Zhong S, Malecek K, Johnson LA, Yu Z, Vega-Saenz de Miera E, Darvishian F, McGary K, Huang K, Boyer J, Corse E, Shao Y, Rosenberg SA, Restifo NP, Osman I, Krogsgaard M. T-cell receptor affinity and avidity defines antitumor response and autoimmunity in T-cell immunotherapy. Proceedings of the National Academy of Sciences of the United States of America. 110: 6973-8. PMID 23576742 DOI: 10.1073/pnas.1221609110 |
0.811 |
|
2013 |
Malecek K, Zhong S, McGary K, Yu C, Huang K, Johnson LA, Rosenberg SA, Krogsgaard M. Engineering improved T cell receptors using an alanine-scan guided T cell display selection system. Journal of Immunological Methods. 392: 1-11. PMID 23500145 DOI: 10.1016/J.Jim.2013.02.018 |
0.801 |
|
2013 |
Wan Q, Kozhaya L, Imberg K, Mercer F, Zhong S, Krogsgaard M, Unutmaz D. Probing the effector and suppressive functions of human T cell subsets using antigen-specific engineered T cell receptors. Plos One. 8: e56302. PMID 23437112 DOI: 10.1371/Journal.Pone.0056302 |
0.589 |
|
2013 |
Wan Q, Kozhaya L, Imberg K, Mercer F, Zhong S, Krogsgaard M, Unutmaz D. Correction: Probing the Effector and Suppressive Functions of Human T Cell Subsets Using Antigen-Specific Engineered T Cell Receptors Plos One. 8. DOI: 10.1371/annotation/cbc71d72-f1a2-45de-9d4a-cb0c8dc076b5 |
0.472 |
|
2012 |
Chandra S, Ding Y, Ma MW, Bannan M, Darvishian F, Berman RS, Shapiro R, Krogsgaard M, Osman I, Pavlick AC. TILs in metastatic melanoma tumors: A biomarker for immunotherapy? Journal of Clinical Oncology. 30: 8589-8589. DOI: 10.1200/Jco.2012.30.15_Suppl.8589 |
0.316 |
|
2012 |
Park J, Zhong S, Krogsgaard M, Mazumder A. MAGE-A3 Specific T-Cell Receptor Adoptive Cell Transfer of Multiple Myeloma Blood. 120: 1843-1843. DOI: 10.1182/Blood.V120.21.1843.1843 |
0.465 |
|
2011 |
Krogsgaard M, Ma MW, Friedman EB, Vega-Saenz de Miera E, Darvishian F, Perez-Garcia A, Berman RS, Shapiro RL, Christos PJ, Osman I, Pavlick AC. An analysis of altered melanoma matrix metalloproteinase-23 (MMP-23) expression and response to immune biologic therapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 8541. PMID 28021075 DOI: 10.1200/Jco.2011.29.15_Suppl.8541 |
0.437 |
|
2010 |
Zhong S, Malecek K, Perez-Garcia A, Krogsgaard M. Retroviral transduction of T-cell receptors in mouse T-cells. Journal of Visualized Experiments : Jove. PMID 21048669 DOI: 10.3791/2307 |
0.802 |
|
2010 |
Corse E, Gottschalk RA, Krogsgaard M, Allison JP. Attenuated T cell responses to a high-potency ligand in vivo. Plos Biology. 8. PMID 20856903 DOI: 10.1371/Journal.Pbio.1000481 |
0.595 |
|
2010 |
Juang J, Ebert PJ, Feng D, Garcia KC, Krogsgaard M, Davis MM. Peptide-MHC heterodimers show that thymic positive selection requires a more restricted set of self-peptides than negative selection. The Journal of Experimental Medicine. 207: 1223-34. PMID 20457759 DOI: 10.1084/Jem.20092170 |
0.365 |
|
2009 |
Call MJ, Xing X, Cuny GD, Seth NP, Altmann DM, Fugger L, Krogsgaard M, Stein RL, Wucherpfennig KW. In vivo enhancement of peptide display by MHC class II molecules with small molecule catalysts of peptide exchange. Journal of Immunology (Baltimore, Md. : 1950). 182: 6342-52. PMID 19414787 DOI: 10.4049/Jimmunol.0803464 |
0.306 |
|
2007 |
Krogsgaard M, Juang J, Davis MM. A role for "self" in T-cell activation. Seminars in Immunology. 19: 236-44. PMID 17548210 DOI: 10.1016/J.Smim.2007.04.003 |
0.563 |
|
2007 |
Davis MM, Krogsgaard M, Huse M, Huppa J, Lillemeier BF, Li QJ. T cells as a self-referential, sensory organ. Annual Review of Immunology. 25: 681-95. PMID 17291190 DOI: 10.1146/Annurev.Immunol.24.021605.090600 |
0.545 |
|
2006 |
Qi S, Krogsgaard M, Davis MM, Chakraborty AK. Molecular flexibility can influence the stimulatory ability of receptor-ligand interactions at cell-cell junctions. Proceedings of the National Academy of Sciences of the United States of America. 103: 4416-21. PMID 16537380 DOI: 10.1073/Pnas.0510991103 |
0.454 |
|
2005 |
Maynard J, Adams EJ, Krogsgaard M, Petersson K, Liu CW, Garcia KC. High-level bacterial secretion of single-chain αβ T-cell receptors Journal of Immunological Methods. 306: 51-67. PMID 16198365 DOI: 10.1016/J.Jim.2005.07.022 |
0.346 |
|
2005 |
Krogsgaard M, Li QJ, Sumen C, Huppa JB, Huse M, Davis MM. Agonist/endogenous peptide-MHC heterodimers drive T cell activation and sensitivity. Nature. 434: 238-43. PMID 15724150 DOI: 10.1038/Nature03391 |
0.483 |
|
2005 |
Krogsgaard M, Davis MM. How T cells 'see' antigen. Nature Immunology. 6: 239-45. PMID 15716973 DOI: 10.1038/Ni1173 |
0.516 |
|
2004 |
Ranheim EA, Tarbell KV, Krogsgaard M, Mallet-Designe V, Teyton L, McDevitt HO, Weissman IL. Selection of aberrant class II restricted CD8+ T cells in NOD mice expressing a glutamic acid decarboxylase (GAD)65-specific T cell receptor transgene. Autoimmunity. 37: 555-67. PMID 15763918 DOI: 10.1080/08916930400020545 |
0.309 |
|
2003 |
Krogsgaard M, Huppa JB, Purbhoo MA, Davis MM. Linking molecular and cellular events in T-cell activation and synapse formation. Seminars in Immunology. 15: 307-15. PMID 15001169 DOI: 10.1016/J.Smim.2003.09.002 |
0.447 |
|
2003 |
Krogsgaard M, Prado N, Adams EJ, He XL, Chow DC, Wilson DB, Garcia KC, Davis MM. Evidence that Structural Rearrangements and/or Flexibility during TCR Binding Can Contribute to T Cell Activation Molecular Cell. 12: 1367-1378. PMID 14690592 DOI: 10.1016/S1097-2765(03)00474-X |
0.38 |
|
2003 |
Davis MM, Krogsgaard M, Huppa JB, Sumen C, Purbhoo MA, Irvine DJ, Wu LC, Ehrlich L. Dynamics of cell surface molecules during T cell recognition. Annual Review of Biochemistry. 72: 717-42. PMID 14527326 DOI: 10.1146/Annurev.Biochem.72.121801.161625 |
0.483 |
|
2003 |
Anikeeva N, Lebedeva T, Krogsgaard M, Tetin SY, Martinez-Hackert E, Kalams SA, Davis MM, Sykulev Y. Distinct molecular mechanisms account for the specificity of two different T-cell receptors. Biochemistry. 42: 4709-16. PMID 12705834 DOI: 10.1021/BI026864+ |
0.312 |
|
2002 |
Irvine DJ, Purbhoo MA, Krogsgaard M, Davis MM. Direct observation of ligand recognition by T cells. Nature. 419: 845-9. PMID 12397360 DOI: 10.1038/Nature01076 |
0.489 |
|
Show low-probability matches. |